Table 2. Prognostic factors for cancer-specific survival in all patients with ESCC.
Variables | Patients (n = 191) | Category or characteristics | Univariate analyses | Multivariate analyses | ||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |||
Gender | 22/169 | (female/male) | 1.310 | 0.599–2.867 | 0.4993 | |||
Age | 81/110 | (<65 / ≥65) | 0.961 | 0.594–1.554 | 0.8713 | |||
BMI | 144/47 | (≥18.5 / <18.5) | 1.616 | 0.946–2.758 | 0.0787 | |||
Alb | 159/32 | (≥3.5 / <3.5) | 2.747 | 1.557–4.845 | 0.0005 | 2.498 | 1.333–4.684 | 0.0043 |
CRP | 148/43 | (<0.5 / ≥0.5) | 2.262 | 1.344–3.807 | 0.0021 | 1.205 | 0.673–2.157 | 0.5300 |
GNRI | 110/81 | (≥97.1 / <97.1) | 2.879 | 1.764–4.698 | < 0.0001 | 1.941 | 1.120–3.365 | 0.0181 |
Tumor size | 54/136 | (<3 / ≥3) | 2.704 | 1.415–5.170 | 0.0026 | 1.229 | 0.614–2.461 | 0.5600 |
pTNM stage | 114/77 | (I, II / III) | 4.600 | 2.747–7.704 | < 0.0001 | 3.884 | 2.229–6.769 | < 0.0001 |
Differentiation | 64/127 | (well / other) | 1.908 | 1.074–3.390 | 0.0276 | 2.307 | 1.262–4.220 | 0.0066 |
SCC | 139/52 | (<1.5 / ≥1.5) | 1.546 | 0.921–2.595 | 0.0990 |